BRIP1 and cancer: The BRIP1 c.104_108del (p.Gly35fs*32) variant, which results in a frameshift and subsequent loss of function, may compromise the cell’s ability to repair DNA double-strand breaks, leading to increased mutational burden and cancer risk.